Natural history of gastro‐oesophageal reflux disease: the neglected factor

References

• Wienbeck M, Barnet J. Epidemiology of reflux disease and reflux esophagitis. Scand J Gastroenterol 1989;24 Suppl 1567–13.
   Google Scholar
• Brunnen PL, Karmody AM. Needham CD: severe peptic oesophagitis. Gut 1969;10:831–7.
   PubMed Web of Science ®Google Scholar
• Behar J, Brand DL, Brown FC, Castell DO, Cohen S, Crossley RJ, et al. Cimetidine in the treatment of symptomatic gastroesophageal reflux. Gastroenterology 1978;74:441–8.
   PubMed Web of Science ®Google Scholar
• Wesdorp ICE, Dekker W, Klinkenberg-Knol EC. Treatment of reflux oesophagitis with ranitidine. Gut 1983;24:921–4.
   Google Scholar
• Hetzel DJ, Dent J, Reed WD, Narielvala FM, MacKinnon M, McCarthy JH, et al. Healing and relapse of severe peptic esophagitis after treatment with omeprazole. Gastroenterology 1988;95:903–12.
   PubMed Web of Science ®Google Scholar
• Kaul B, Petersen H, Erichsen H, Myrvold HE, Grette K, Halvorsen T, et al. Gastroesophageal reflux disease. Acute and maintenance treatments with cimetidine. Scand J Gastroenterol 1986;21:139–45.
   PubMed Web of Science ®Google Scholar
• Lind T, Havelund T, Carlsson R, Anker-Hansen O, Glise H, Hernqvist H, et al. Heartburn without oesophagitis: efficacy of omeprazole therapy and features determining therapeutic response. Scand Gastroenterol 1997;32:974–9.
   Google Scholar
• Bate CM, Griffin SM, Keeling PW, Axon ATR, Dronfields MW, Chapman RWG, et al. Reflux symptom relief with omeprazole in patients without unequivocal oesophagitis. Aliment Pharmacol Ther 1996;10:547–55.
   PubMed Web of Science ®Google Scholar
• Galmiche JP, Barthelemy P, Hamelin B. Treating the symptoms of gastro-esophageal reflux disease: a double-blind comparison of omeprazole and cisapride. Aliment Pharmacol Ther 1997;11:765–73.
   Google Scholar
• Wesdorp E, Bartelsman J, Pape K, Dekker W, Tytgat GN. Oral cimetidine in reflux esophagitis: a double blind controlled trial. Gastroenterology 1978;74:821–4.
   Google Scholar
• Carlsson R, Dent J, Watts R, Riley S, Sheikh R, Hathebakk J, et al. Gastroesophageal reflux disease (GORD) in primary care. An international study in different treatment strategies with omeprazole. Eur J Gastrointest Hepatol 1998;10:119–24.
   Google Scholar
• Koelz HR, Birchler R, Bretholz A, Bron B, Capitaine Y, Delmore G, et al. Healing and relapse of reflux esophagitis during treatment with ranitidine. Gastroenterology 1986; 91: 1198–205.
   PubMed Web of Science ®Google Scholar
• Sandmark S, Carlsson R, Fausa O, Lundell L. Omeprazole or ranitidine in the treatment of reflux esophagitis. Results of a double-blind, randomized, Scandinavian multicenter study. Scand J Gastroenterol 1988;23:625–32.
   PubMed Web of Science ®Google Scholar
• Lieberman DA. Medical therapy for chronic esophagitis. Arch Intern Med 1987;147:1717–20.
   PubMedGoogle Scholar
• Robinson M, Lanza F, Avner D, Haber M. Effective maintenance treatment of reflux esophagitis with low-dose of lansoprazole: a randomized double-blind, placebo controlled trial. Ann Intern Med 1996;124:859–67.
   PubMed Web of Science ®Google Scholar
• Blum AL, Adami B, Bouzo MH, Brandstatter G, Fumagalli I, Galmiche JP, et al. Effect of cisapride on relapse of esophagitis: a multinational, placebo-controlled trial in patients healed with an antisecretory drug. Dig Dis Sci 1993;38:551–60.
   PubMed Web of Science ®Google Scholar
• Lind T, Havelund T, Lundell L, Glise H, Lauritsen K, Pedersen S-A, et al. On demand therapy with omeprazole for the long-term management of patients with heartburn without oesophagitis: a placebo-controlled randomized trial. Aliment Pharmacol Ther 1999;13:907–14.
   Google Scholar
• Venables TL, Newland RD, Patel AC, Hole J, Copeman MB, Turbitt ML. Maintenance treatment for gastro-esophageal reflux disease. A placebo-controlled evaluation of 10 milligrams omeprazole once daily in general practice. Scand J Gastroenterol 1997;32:627–32.
   Google Scholar
• Pace F, Santalucia F, Bianchi Porro G. Natural history of gastroesophageal reflux disease without oesophagitis. Gut 1991; 32: 845–8.
   Google Scholar
• Klinkenberg-Knol EC, Jansen JBMJ, Lamers CBHW, Nelis F, Meuwissen SGM. Temporary cessation of long-term maintenance treatment with omeprazole in patients with H2-receptor- agonist-resistant reflux oesophagitis. Scand J Gastroenterol 1990; 25:1144–50.
   Google Scholar
• Palmer ED. The hiatus hernia-esophagitis-esophageal stricture complex. Twenty-year prospective study. Am J Med 1968; 44: 566–79.
   Google Scholar
• Rex JC, Andersen HA, Bartholomew LG, Cain JC. Esophageal hiatal hernia: a 10-year study of medically treated cases. JAMA 1961;178:117–20.
   Web of Science ®Google Scholar
• Behar J, Sheahan DG, Biancani P, Spiro HM, Storer M. Medical and surgical management of reflux esophagitis. A 38-month report on a prospective clinical trial. N Engl J Med 1975; 293: 263–8.
   Google Scholar
• Palmer ED. Subacute erosive (‘peptic’) esophagitis: histopathologic study. Arch Pathol 1955;59:51–9.
   Google Scholar
• Kuster E, Ros E, Toledo-Pimentel V, Pujol A, Bordas JM, Grande L. Predictive factors of the long term outcome in gastro- oesophageal reflux disease: six year follow-up. Gut 1994;35:8–14.
   Google Scholar
• Isolauri J, Loustarinen M, Isolauri E, Reinikainen P, Viljakka M, Keyrilainen O. Natural course of gastroesophageal reflux disease: 17–22 year follow-up of 60 patients. Am J Gastroenterol 1997;92:37–41.
   PubMed Web of Science ®Google Scholar
• McDougall NI, Johnston BT, Collins JSA, McFarland RJ, Love AHG. Three to 4.5 year prospective study of prospective indicators in gastro-oesophageal reflux disease. Scand J Gastroenterol 1998;33: 1016–22.
   Google Scholar
• Schindlbeck NE, Klauser AG, Berghammer G, London GW, Muller-Lissner SA. Three years follow up of patients with gastroesophageal reflux disease. Gut 1992;33:1016–9.
   Google Scholar
• Poynard T. French Co-operative Study Group. Relapse rate of patients after healing of oesophagitis: a prospective study of alginate as self-care treatment for 6 months. Aliment Pharmacol Ther 1993;7: 385–92.
   Google Scholar
• Glise H. Healing, relapse rates and prophylaxis of reflux esophagitis. Scand J Gastroenterol 1989;24 Suppl 156: 64–7.
   Google Scholar
• Schwizer W, Thumshirn M, Dent J, Guldenschuh, Menne D, Cathomas G. Helicobacter pylori and symptomatic relapse of gastro-oesophageal reflux disease: a randomised controlled trial. Lancet 2001;357:1738–42.
   PubMed Web of Science ®Google Scholar
• Moayyedi P, Bardhan C, Young L, Dixon MF, Brown L, Axon ATR. Helicobacter pylori eradication does not acerbate reflux symptoms in gastroesophageal reflux disease. Gastroenterology 2001;121:1120–6.
   PubMed Web of Science ®Google Scholar
• Carlsson R, Galmiche JP, Dent J, Lundell L, Frison L. Prognostic factors influencing relapse of oesophagitis during maintenance therapy with antisecretory drugs: a meta-analysis of long term omeprazole trials. Aliment Pharmacol Ther 1997;11:473–82.
   Google Scholar
• El-Serag HB, Sonnenberg A. Associations between different forms of gastro-esophageal reflux disease. Gut 1997;41:594–9.
   Google Scholar
• Jones MP, Sloan SS, Rabine JC, Ebert CC, Huang CF, Kahrilas PJ. Hiatal hernia size is the dominant determinant of esophagitis presence and severity in gastroesophageal reflux disease. Am J Gastroenterol 2001;96:1712–7.
   Google Scholar
• Cadiot G, Bruhat A, Rigaud D, Coste T, Vuagnat A, Benyedder Y, et al. Multivariate analysis of pathophysiological factors in reflux oesophagitis. Gut 1997;40:167–74.
   PubMed Web of Science ®Google Scholar
• Avidan B, Sonnenberg A, Schnell TG, Sontag SJ. Risk factors for erosive reflux esophagitis: a case-control study. Am J Gastroenterol 2001;96:41–6.
   PubMed Web of Science ®Google Scholar
• Wilson LJ, Ma W, Hirschowitz BI. Association of obesity with hiatal hernia and esophagitis. Am J Gastroenterol 1999; 94: 2840–4.
   Google Scholar
• Patti MG, Goldberg HI, Arcerito M, Bortolasi L, Tong J, Way LW. Hiatal hernia size affects lower esophageal sphincter function, esophageal acid exposure, and the degree of mucosal injury. Am J Surg 1996;171:182–6.
   PubMed Web of Science ®Google Scholar
• Havelund T, Laursen LS, Skoubo-Kristensen E, Andersen BN, Pedersen SA. Omeprazole and ranitidine in treatment of reflux esophagitis. Double blind comparative trial. BrMed J 1988;296: 89–92.
   Google Scholar
• Olden K, Triadofilopoulos G. Failure of initial 24-hour esophageal pH monitoring to predict refractoriness and intractability in reflux esophagitis. Am J Gastroenterol 1991;86:1142–6.
   PubMed Web of Science ®Google Scholar
• Tytgat GN, Anker Hansen OJ, Carling L, deGroot GH, Geldof H, Glise H. Effect of cisapride on relapse of severe peptic oesophagitis, healed with an antisecretory drug. Scand J Gastroenterol 1992;27:175–83.
   PubMed Web of Science ®Google Scholar
• Ollyo JB, Monnier P, Fontolliet C, Savary M. The natural history, prevalence and incidence of reflux esophagitis. Gullet 1993;3 Suppl 3–10.
   Google Scholar
• Bate CM, Booth SN, Crowe JP, Mountford RA, Keeling PWN, Hepworth-Jones B, et al. Omeprazole 10 mg or 20 mg once daily in the prevention of recurrence of oesophagitis. Gut 1995; 36: 492–8.
   Google Scholar
• Kjellin A, Ramel S, Rossner S, Thor K. Gastroesophageal reflux in obese patients is not reduced by weight reduction. Scand J Gastroenterol 1996;31:1047–51.
   PubMed Web of Science ®Google Scholar
• Mathus-Vliegen LM, Tygat GN. Twenty-four hour pH measurements in morbid obesity: effects of massive overweight, weight loss and gastric distension. Eur J Gastroenterol Hepatol 1996;8: 635–40.
   Google Scholar
• Paterson WG. Role of mast cell-derived mediators in acid- induced shortening of esophagus. Am J Physiol 1998; 274: G385–8.
   PubMed Web of Science ®Google Scholar
• Bor S, Caymaz-Bor C, Tobey NA, Abdulnour-Nakhoul S, Marten E, Orlando RC. Effect of ethanol on the structure and function of rabbit esophageal epithelium. Am J Physiol 1998; 274:G819–26.
   Google Scholar
• Kahrilas PJ, Gupta RR. Mechanisms of acid reflux associated with cigarette smoking. Gut 1990;31:4–10.
   PubMed Web of Science ®Google Scholar
• Masclee AAM, DeBest ACAM, DeGraaf R, Cluysenaer OJJ, Jansen JBMJ. Ambulatory 24-hour pH-metry in the diagnosis of gastroesophageal reflux disease. Scand J Gastroenterol 1990;25: 225–30.
   Google Scholar
• Schlesinger PK, Donhue PE, Schmid B, Layden TJ. Limitation of 24-hour intraesophageal pH monitoring in the hospital setting. Gastroenterology 1985;89:794–804.
   Google Scholar
• Smout AJPM. Endoscopy-negative acid reflux disease. Aliment Pharmacol Ther 1997;111 Suppl 2: 81–5.
   Google Scholar
• Koufman JA, Belafsky PC, Bach KK, Daniel E, Postma GN. Prevalence of esophagitis in patients with pH-documented laryngopharyngeal reflux. Laryngoscope 2002;112:1606–9.
   Google Scholar
• Orlando RC. Reflux esophagitis. In: Yamada T, editor. Textbook of Gastroenterology. Philadelphia: J. B. Lippincott; 1995.
   Google Scholar
• Rodrigo J, Hernandez DJ, Vidal MA, Pedrosa JA. Vegetative innervation of the esophagus III. Intraepithelial endings. Acta Anat 1975;92:242–58.
   PubMed Web of Science ®Google Scholar
• Tobey NA, Carson JL, Alkiek RA, Orlando RC. Dilated intercellular spaces: a morphological feature of acid-reflux damaged human esophageal epithelium. Gastroenterology 1996;111:1200–5.
   PubMed Web of Science ®Google Scholar
• Calabrese C, Bortolotti M, Fabbri A, Areni A, Benni M, Scialo C, et al. Dilated intercellular spaces of human esophageal epithelium as the first and most sensitive marker of damage in GERD. Gastroenterology 2002;122:A577.
   Google Scholar
• Solcia E, Villani L, Luinetti O, Trespi E, Strada E, Tinelli C, et al. Altered intercellular glycoconjugates and dilated intercellular paces of esophageal epithelium in reflux disease. Virchows Arch 2000;436:207–16.
   PubMed Web of Science ®Google Scholar
• Carlsson R, Fandriks L, Jonsson C, Lundell L, Orlando RC. Is the esophageal squamous epithelial barrier function impaired in patients with gastroesophageal reflux disease? Scand J Gastroenterol 1999;34:454–8.
   Google Scholar